FDA approves first generic atomoxetine for the treatment of ADHD
admin 13th June 2017 Uncategorised 0American Pharmacists Association News
More: FDA approves first generic atomoxetine for the treatment of ADHD
Source: MDlinx
American Pharmacists Association News
More: FDA approves first generic atomoxetine for the treatment of ADHD
Source: MDlinx
Data favor Merck, Eisai’s Keytruda-Lenvima as the winner in kidney cancer, but window still open for Bristol Myers: analyst
Data favor Merck, Eisai’s Keytruda-Lenvima as the winner in kidney
FDA could reject AstraZeneca’s COVID vaccine on efficacy and manufacturing shortfalls: analyst
FDA could reject AstraZeneca’s COVID vaccine on efficacy and manufa
Pfizer, Moderna pledge more mRNA vaccine doses to Europe after AZ supply concerns
Pfizer, Moderna pledge more mRNA vaccine doses to Europe after AZ sup
M | T | W | T | F | S | S |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 |
8 | 9 | 10 | 11 | 12 | 13 | 14 |
15 | 16 | 17 | 18 | 19 | 20 | 21 |
22 | 23 | 24 | 25 | 26 | 27 | 28 |
29 | 30 | 31 |
© 1994 - 2021 B.M. Pharmaceuticals